Prediction Model of Serum Lithium Concentrations

Abstract

Introduction Therapeutic drug monitoring is necessary for lithium, but clinical application of several prediction strategies is still limited because of insufficient predictive accuracy. We herein proposed a suitable model, using creatinine clearance (CLcr)-based lithium clearance (Li-CL).

Methods Patients receiving lithium provided the following information: serum lithium and creatinine concentrations, time of blood draw, dosing regimen, concomitant medications, and demographics. Li-CL was calculated as a daily dose per trough concentration for each subject, and the mean of Li-CL/CLcr was used to estimate Li-CL for another 30 subjects. Serum lithium concentrations at the time of sampling were estimated by 1-compartment model with Li-CL, fixed distribution volume (0.79 L/kg), and absorption rate (1.5/hour) in the 30 subjects.

Results One hundred thirty-one samples from 82 subjects (44 men; mean±standard deviation age: 51.4±16.0 years; body weight: 64.6±13.8 kg; serum creatinine: 0.78±0.20 mg/dL; dose of lithium: 680.2±289.1 mg/day) were used to develop the pharmacokinetic model. The mean±standard deviation (95% confidence interval) of absolute error was 0.13±0.09 (0.10–0.16) mEq/L.

Discussion Serum concentrations of lithium can be predicted from oral dosage with high precision, using our prediction model.

Key words

lithium - prediction - therapeutic drug monitoring

• References

• 1 Suppes T, Dennehy EB, Hirschfeld RMA. et al. The Texas implementation of medication algorithms: Update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. 2005; 66: 870-886
• 2 McAllister-Williams RH. Relapse prevention in bipolar disorder: A critical review of current guidelines. J Psychopharmacol. 2006; 20: 12-16
• 3 Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring. CNS Drugs 2009; 23: 331-349
• 4 Deacon B, Abramowitz J. Fear of needles and vasovagal reactions among phlebotomy patients. J Anxiety Disord. 2006; 20: 946-960
• 5 Sienaert P, Geeraerts I, Wyckaert S. How to initiate lithium therapy a systematic review of dose estimation and level prediction methods. J Affect Disord. 2013; 146: 15-33
• 6 Pepin SM, Baker DE, Nance KS. Proceedings of the 15th Annual ASHP midyear clinical meeting, San Francisco, CA, December 1980.
• 7 Zetin M, Garber D, De Antonio M. et al. Prediction of lithium dose: A mathematical alternative to the test-dose method. J Clin Psychiatry. 1986; 47: 175-178
• 8 Abou-Auda HS, Al-Yamani MJ, Abou-Shaaban RR. et al. A new accurate method for predicting lithium clearance and daily dosage requirements in adult psychiatric patients. Bipolar Disord. 2008; 10: 369-376
• 9 Radhakrishnan R, Kanigere M, Menon J. et al. Comparison of three a-priori models in the prediction of serum lithium concentration. Indian J Pharmacol. 2012; 44: 234-235
• 10 Terao T, Okuno K, Okuno T. et al. A simpler and more accurate equation to predict daily lithium dose. J Clin Psychopharmacol. 1999; 19: 336-340
• 11 Cooper TB, Bergner PE, Simpson GM. The 24-hour serum lithium level as a prognosticator of dosage requirements. Am J Psychiatry. 1973; 130: 601-603
• 12 Mason RW, McQueen EG, Keary PJ. et al. Pharmacokinetics of lithium: Elimination half-time, renal clearance and apparent volume of distribution in schizophrenia. Clin Pharmacokinet. 1978; 3: 241-246
• 13 Huang HC, Chang YL, Lan TH. et al. Prediction of optimal lithium doses for Taiwanese psychiatric patients. J Clin Pharm Ther. 2008; 33: 115-121
• 14 Pharmaceuticals and Medical Devices Agency. PMDA alert for proper use of drugs.Available at http://www.pmda.go.jp/files/000153187.pdf Accessed on: January 7, 2017
• 15 Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
• 16 Winter EM. Basic clinical pharmacokinetics (Japanese). Toyko: JIHO Co Ltd; 2005: 95-98
• 17 Interview Form of LIMAS® (Japanese). http://medical.taishotoyama.co.jp/data/if/pdf/li.pdf Accessed on: March 3, 2017
• 18 Sampson M, Ruddel M, Elin RJ. Lithium determinations evaluated in eight analyzers. Clin Chem. 1994; 40: 869-872
• 19 Aliasgharpour M, Hagani H. Evaluation of lithium determination in three analyzers: Flame emission, flame atomic absorption spectroscopy and ion selective electrode. N Am J Med Sci. 2009; 1: 244-246
• 20 Delattre IK, Van de Walle P, Van Campenhout C. et al. How appropriate is therapeutic drug monitoring for lithium? Data from the Belgian external quality assessment scheme. Clin Biochem. 2015; 48: 617-621
• 21 Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm. 1981; 9: 503-512
• 22 Jermain DM, Crismon ML, Martin ES. Population pharmacokinetics of lithium. Clin Pharm. 1991; 10: 376-381
• 23 Yukawa E, Nomiyama N, Higuchi S. et al. Lithium population pharmacokinetics from routine clinical data: Role of patient characteristics for estimating dosing regimens. Ther Drug Monit. 1993; 15: 75-82
• 24 Higuchi S. Fact of TDM for drug dosage design. In: Iga T, Saito Y. eds. Tokyo: Yakugyozihousha Co Ltd; 1993: 274-292
• 25 Thomsen K, Shirley DG. The validity of lithium clearance as an index of sodium and water delivery from the proximal tubules. Nephron 1997; 77: 125-138
• 26 Grant MS. The effect of blood drawing techniques and equipment on the hemolysis of ED laboratory blood samples. J Emerg Nurs. 2003; 29: 116-121
• 27 DasGupta K, Jefferson JW, Kobak KA. et al. The effect of enalapril on serum lithium levels in healthy men. J Clin Psychiatry. 1992; 53: 398-400
• 28 Finley PR. Drug interactions with lithium: An update. Clin Pharmacokinet. 2016; 55: 925-941
• 29 Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with Lithium. Clin Pharmacokinet. 1995; 29: 172-191
• 30 Alderman CP, Lindsay KS. Increased serum lithium concentration secondary to treatment with tiaprofenic acid fosinopril. Ann Pharmacother. 1996; 30: 1411-1413
• 31 Imbs JL, Barthelmebs M, Danion JM. et al. Mechanisms of drug interactions with renal elimination of lithium. Bull Acad Natl Med. 1997; 181: 685-695
• 32 Wing YK, Chan E, Chan K. et al. Lithium pharmacokinetics in Chinese manic-depressive patients. J Clin Psychopharmacol. 1997; 17: 179-184
• 33 Yang YY, Yeh EK, Chang SS. et al. Maintenance lithium levels could be lowered: Based on Taiwanese and Danish studies. J Formos Med Assoc. 1991; 90: 509-513